These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 29300929)
41. XIAP inhibition and generation of reactive oxygen species enhances TRAIL sensitivity in inflammatory breast cancer cells. Allensworth JL; Aird KM; Aldrich AJ; Batinic-Haberle I; Devi GR Mol Cancer Ther; 2012 Jul; 11(7):1518-27. PubMed ID: 22508521 [TBL] [Abstract][Full Text] [Related]
42. The caspase-8/Bid/cytochrome c axis links signals from death receptors to mitochondrial reactive oxygen species production. Kim WS; Lee KS; Kim JH; Kim CK; Lee G; Choe J; Won MH; Kim TH; Jeoung D; Lee H; Kim JY; Ae Jeong M; Ha KS; Kwon YG; Kim YM Free Radic Biol Med; 2017 Nov; 112():567-577. PubMed ID: 28888620 [TBL] [Abstract][Full Text] [Related]
43. Bakuchiol sensitizes cancer cells to TRAIL through ROS- and JNK-mediated upregulation of death receptors and downregulation of survival proteins. Park MH; Kim JH; Chung YH; Lee SH Biochem Biophys Res Commun; 2016 Apr; 473(2):586-92. PubMed ID: 27033605 [TBL] [Abstract][Full Text] [Related]
44. Bortezomib primes neuroblastoma cells for TRAIL-induced apoptosis by linking the death receptor to the mitochondrial pathway. Naumann I; Kappler R; von Schweinitz D; Debatin KM; Fulda S Clin Cancer Res; 2011 May; 17(10):3204-18. PubMed ID: 21459798 [TBL] [Abstract][Full Text] [Related]
45. DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells. Degl'Innocenti D; Romeo P; Tarantino E; Sensi M; Cassinelli G; Catalano V; Lanzi C; Perrone F; Pilotti S; Seregni E; Pierotti MA; Greco A; Borrello MG Endocr Relat Cancer; 2013 Feb; 20(1):23-37. PubMed ID: 23132790 [TBL] [Abstract][Full Text] [Related]
46. Knockdown of miR-25 increases the sensitivity of liver cancer stem cells to TRAIL-induced apoptosis via PTEN/PI3K/Akt/Bad signaling pathway. Feng X; Jiang J; Shi S; Xie H; Zhou L; Zheng S Int J Oncol; 2016 Dec; 49(6):2600-2610. PubMed ID: 27840896 [TBL] [Abstract][Full Text] [Related]
47. The flavonolignan silibinin potentiates TRAIL-induced apoptosis in human colon adenocarcinoma and in derived TRAIL-resistant metastatic cells. Kauntz H; Bousserouel S; Gossé F; Raul F Apoptosis; 2012 Aug; 17(8):797-809. PubMed ID: 22555452 [TBL] [Abstract][Full Text] [Related]
48. Linarin sensitizes tumor necrosis factor-related apoptosis (TRAIL)-induced ligand-triggered apoptosis in human glioma cells and in xenograft nude mice. Xu ZF; Sun XK; Lan Y; Han C; Zhang YD; Chen G Biomed Pharmacother; 2017 Nov; 95():1607-1618. PubMed ID: 28950661 [TBL] [Abstract][Full Text] [Related]
49. Camptothecin sensitizes human hepatoma Hep3B cells to TRAIL-mediated apoptosis via ROS-dependent death receptor 5 upregulation with the involvement of MAPKs. Jayasooriya RG; Choi YH; Hyun JW; Kim GY Environ Toxicol Pharmacol; 2014 Nov; 38(3):959-67. PubMed ID: 25461556 [TBL] [Abstract][Full Text] [Related]
50. Acrolein sensitizes human renal cancer Caki cells to TRAIL-induced apoptosis via ROS-mediated up-regulation of death receptor-5 (DR5) and down-regulation of Bcl-2. Yang ES; Woo SM; Choi KS; Kwon TK Exp Cell Res; 2011 Nov; 317(18):2592-601. PubMed ID: 21854768 [TBL] [Abstract][Full Text] [Related]
51. BRAFV600E mutation and X-linked inhibitor of apoptosis expression in papillary thyroid carcinoma. Gu LQ; Li FY; Zhao L; Liu Y; Zang XX; Wang TX; Chen HP; Ning G; Zhao YJ Thyroid; 2009 Apr; 19(4):347-54. PubMed ID: 19355825 [TBL] [Abstract][Full Text] [Related]
52. Casticin, a flavonoid, potentiates TRAIL-induced apoptosis through modulation of anti-apoptotic proteins and death receptor 5 in colon cancer cells. Tang SY; Zhong MZ; Yuan GJ; Hou SP; Yin LL; Jiang H; Yu ZΥ Oncol Rep; 2013 Feb; 29(2):474-80. PubMed ID: 23135489 [TBL] [Abstract][Full Text] [Related]
53. J7, a methyl jasmonate derivative, enhances TRAIL-mediated apoptosis through up-regulation of reactive oxygen species generation in human hepatoma HepG2 cells. Park C; Jin CY; Hwang HJ; Kim GY; Jung JH; Kim WJ; Yoo YH; Choi YH Toxicol In Vitro; 2012 Feb; 26(1):86-93. PubMed ID: 22079975 [TBL] [Abstract][Full Text] [Related]
54. R-roscovitine sensitizes anaplastic thyroid carcinoma cells to TRAIL-induced apoptosis via regulation of IKK/NF-kappaB pathway. Festa M; Petrella A; Alfano S; Parente L Int J Cancer; 2009 Jun; 124(11):2728-36. PubMed ID: 19230027 [TBL] [Abstract][Full Text] [Related]
55. ZNRF3 is downregulated in papillary thyroid carcinoma and suppresses the proliferation and invasion of papillary thyroid cancer cells. Qiu W; Yang Z; Fan Y; Zheng Q Tumour Biol; 2016 Sep; 37(9):12665-12672. PubMed ID: 27448298 [TBL] [Abstract][Full Text] [Related]
56. AY4, an agonistic anti-death receptor 4 MAB, induces apoptotic cell death in anaplastic thyroid cancer cells via downregulation of Bcl-xL with reactive oxygen species generation. Lee BS; Cha HY; Shin YS; Kim YS; Kim CH Endocr Relat Cancer; 2013 Jun; 20(3):283-91. PubMed ID: 23429749 [TBL] [Abstract][Full Text] [Related]
57. Silencing Daxx increases the anti-tumor activity of a TRAIL/shRNA Bcl-xL-expressing oncolytic adenovirus through enhanced viral replication and cellular arrest. Kang S; Kang D; Bakhtiar Ul Islam SM; Je S; Kim JH; Song JJ Cell Signal; 2015 Jun; 27(6):1214-24. PubMed ID: 25748050 [TBL] [Abstract][Full Text] [Related]